he's also on the board of airbus. what kind of data are we talking about that your business is enabling companies to access and analyze? >> we analyze anonymized patient data in partnership with nhs trust. that allows us to ask questions of the data to help companies how to improve lyrical trials, how to understand the complexity of medicine to be able to analyze digital patient records, to see the hidden patterns in that data. it leads to new discoveries to accelerate medical research. nejra: is this data and demand from pharmaceutical companies globally? >> yes. there is a growing recognition that the ability to get real-world evidence from digital patient records, once they have been anonymized, can be very useful in accelerating the